(EVLV) Evolv Technologies Holdings, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(EVLV) Evolv Technologies Holdings, Inc. Complete Analysis Pack
Download Your Competitive Advantage
This Evolv Technologies Holdings, Inc. BCG Matrix helps you quickly see how the company’s products or business units may fit into Stars, Cash Cows, Question Marks, and Dogs for strategy and capital allocation. The page already shows a real preview of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Stars
Evolv Express flagship platform
Evolv Express is Evolv Technologies Holdings, Inc.'s core AI screening system, and it is the clearest Star in the BCG Matrix. It detects firearms, IEDs, and tactical knives while people keep walking, so it fits the fastest-growing side of security screening and drives most deployments.
Express deployments at high-traffic venues
Express deployments fit best at sports and entertainment venues, where Evolv Technologies Holdings, Inc. can cut screening bottlenecks while improving threat detection. High-traffic sites support repeat demand because operators need faster entry for thousands of visitors per event, and each live deployment becomes a visible reference win. That helps expand share in a niche where speed and safety both matter.
School and campus screening demand
K-12 schools and universities still offer a strong non-invasive screening market, with U.S. school safety spending topping billions each year. Evolv Technologies Holdings, Inc.'s contactless screening fits crowded entrances because it can keep lines moving without manual bag checks. With more than 4,000 systems deployed across schools, venues, and public sites, the school segment has star-like growth potential.
Healthcare entry screening use cases
Healthcare is a strong Stars use case for Evolv Technologies Holdings, Inc. because hospitals need fast screening at public entrances without slowing patient and visitor flow. Evolv Express screens people while they keep pockets and bags on, which fits high-traffic sites where reducing wait time matters as much as security.
This vertical still has room to scale, since large hospital systems, outpatient centers, and medical campuses can add multiple entrances over time. The model supports repeat deployments across facilities, so each new site can expand the installed base and recurring scanner use.
- Fast screening at busy public entrances
- No pocket-emptying or item removal
- Good fit for hospitals and campuses
- Room for multi-site deployment growth
Evolv Edge advanced threat detection
Evolv Edge broadens Evolv Technologies Holdings, Inc. beyond standard weapons screening by targeting non-metallic explosives, firearms, and tactical knives. That makes it a "Star" candidate if adoption scales in schools, venues, and transit, where demand for layered screening stays high.
Evolv Technologies Holdings, Inc. reported revenue growth to about "$106.1 million" in the latest fiscal year, and Edge can help lift average contract value.
- Broader threat coverage
- Higher cross-sell potential
- Star depends on fast adoption
Evolv’s Two Star Products Fuel Fast Growth Across High-Security Venues
Evolv Technologies Holdings, Inc. has two clear Stars: Evolv Express and Evolv Edge. In FY2025, revenue reached $106.1 million and installed systems topped 4,000, showing strong demand in venues, schools, and healthcare where fast, non-invasive screening matters most.
| Star | Fit | Key data |
|---|---|---|
| Evolv Express | Venues, schools, hospitals | Fast walk-through screening |
| Evolv Edge | Layered threat screening | Supports cross-sell growth |
| Company | FY2025 | $106.1 million revenue; 4,000+ systems |
What is included in the product
Detailed Word Document
Evolv’s BCG Matrix maps growth, share, and capital priorities across its security-tech portfolio.
Editable Excel File
Quick BCG view of Evolv Technologies Holdings, Inc. to pinpoint underperformers and growth bets.
Reference Sources
Provides a clear source trail for Evolv Technologies Holdings, Inc. to verify key claims fast and support confident decisions.
Cash Cows
Installed base renewals
Installed base renewals are Evolv Technologies Holdings, Inc.’s closest cash cow: once a site is deployed, replacement and renewal demand can recur with far lower selling cost than new-logo sales. The latest filings show the company is still scaling its customer base, so follow-on revenue from existing sites should be the cheapest way to monetize that base and lift margin over time.
Evolv Insights subscriptions
Evolv Insights subscriptions fit the Cash Cows box because they sell self-serve analytics for visitor flow, arrival curves, performance, detection accuracy, and alarms, so the value is recurring, not one-off. Software renewals usually stick better than new hardware sales, and that steadier cash flow can support margins as accounts expand. If more locations inside the same customer base adopt Evolv Insights, it can mature into a durable recurring revenue stream.
Service and support contracts
Service and support contracts give Evolv Technologies Holdings, Inc. a steadier cash base because security systems need ongoing calibration, customer success coverage, and troubleshooting after install. This revenue is usually lower growth than new deployments, but it is stickier and can smooth cash flow while the company scales. For a hardware-plus-software model, these contracts act like the low-growth layer that helps fund future expansion.
Training and implementation work
Training and implementation work is a cash cow for Evolv Technologies Holdings, Inc. because each large rollout needs onboarding, system setup, and staff training at the same customer site. These fees come from the installed base, so they do not need new market creation. Once the platform is live, the work can produce steady, high-margin service revenue.
Linked to existing sites, not new demand
Supports rollout fees and setup income
Weak growth, but reliable margin
Upgrade and expansion orders
Upgrade and expansion orders are Evolv Technologies Holdings, Inc. Cash Cows because existing customers can add lanes, new entrances, or new sites after the first install. That lowers sales risk versus chasing new logos and creates a steadier repeat-order stream. One clean tell: this is the company’s mature monetization path.
In BCG terms, these orders can help fund the heavy R&D and sales spend needed to grow the platform. For example, if a school, stadium, or hospital expands one site first, later rollouts are often faster and less costly than a full first sale.
Repeat orders are easier to predict.
Expansion spend is tied to installed base.
Mature revenue can offset growth costs.
Evolv’s Installed Base Drives Recurring, High-Margin Revenue
Evolv Technologies Holdings, Inc.’s Cash Cows sit in the installed base: renewals, Evolv Insights subscriptions, support, and training recur after deployment and need less selling spend than new-logo sales. That makes the revenue steadier and usually more margin-rich than first-time hardware deals.
| Cash cow | Why it fits |
|---|---|
| Renewals | Low-cost repeat revenue |
| Insights | Recurring software fees |
| Support | Sticky service income |
In BCG terms, these mature streams can help fund R&D and sales for newer growth areas. The key one-liner: Evolv Technologies Holdings, Inc. monetizes existing sites best after the first install.
Full Version Awaits
Evolv Technologies Holdings, Inc. Reference Sources
You're previewing the exact Evolv Technologies Holdings, Inc. BCG Matrix report you'll receive after purchase. The full document is ready for immediate use, with no demo pages or hidden content.
What you see here is the same professionally formatted file that will be delivered to you. It’s designed for clear strategic review, editing, printing, or presentation.
Once purchased, the complete BCG Matrix is yours instantly. No surprises—just the same analysis-ready document shown in this preview.
Dogs
Standalone pilot-only deployments
Standalone pilot-only deployments fit Dogs: they consume sales and support time but often stay too small to lift Evolv Technologies Holdings, Inc. market share. If a pilot never scales, it can trap cash with little recurring revenue, while the company still carries 2025 operating costs and support effort. For BCG terms, these pilots are the weakest portfolio fit because they can drain resources without changing the growth profile.
Low-volume custom integration work
Low-volume custom integration work at Evolv Technologies Holdings, Inc. fits Dogs because it is narrow, hard to repeat, and tied to one-off customer needs. It does not scale like the core platform, so it usually stays low-share and low-growth. That makes it more of a service expense than a durable franchise.
Small-budget venue deals
Small-budget venue deals fit the Dogs box because very small sites usually have tight security budgets and slower buying cycles, so they often cannot support the same unit economics as arenas, campuses, or hospitals. For Evolv Technologies Holdings, Inc., that makes these deals a low-growth pocket with limited strategic value, especially when larger enterprise sites drive more meaningful recurring revenue and deployment scale.
Non-core international trial markets
Evolv Technologies Holdings, Inc. still treats non-core international trial markets as a small side bet, not a main growth engine. Early overseas rollouts usually face slower procurement, local certification, and longer sales cycles, so share can stay too small to matter. If adoption does not scale fast, these markets fit the "Dogs" box in the BCG Matrix.
- Small share, slow uptake, weak near-term payoff
- Longer procurement and approval cycles
- Not a disclosed core growth driver
Low-attach hardware-only sales
Low-attach hardware-only sales are the weakest Dogs in Evolv Technologies Holdings, Inc.’s BCG mix because they create no recurring renewal stream and little lock-in. In security tech, that means lower lifetime value and more price pressure, while software and service mix usually drives margin strength and retention. Pure hardware deals are one-off revenue, so they are the least durable form of sales.
No recurring software revenue
Weak lock-in and pricing power
Lower lifetime value than bundled deals
Evolv’s Dog Bets: Low-Repeat, Low-LTV, Margin Drag
Dogs at Evolv Technologies Holdings, Inc. are small, low-share bets: pilot-only installs, custom one-offs, tiny sites, non-core overseas trials, and hardware-only sales. They use sales and support time but rarely scale into recurring revenue, so they can drag FY2025 economics without improving growth. The clear signal is weak repeatability and low lifetime value.
| Dog type | Why it fits |
|---|---|
| Pilots | No scale, weak payback |
| Hardware-only | No recurring revenue |
Question Marks
Airports checkpoint screening
Airports are a big security market, and U.S. travel stayed near record levels in 2025, but buying cycles are slower than in venues because certification, passenger flow, and TSA rules matter. That makes airport screening a question mark: high upside, but share is still hard to win. If Evolv turns a few more airport wins into repeat rollouts, this segment could move toward star status.
Mass transit and rail hubs
Mass transit and rail hubs fit Evolv Technologies Holdings, Inc. in question-mark territory: the need for fast passenger throughput and better threat detection is real, but sales cycles are long and rivals are strong. Transit buyers often want proof from live deployments before scaling, so wins can be slow even when demand is attractive. That makes this a high-upside but low-visibility segment for Evolv Technologies Holdings, Inc.
Government and critical infrastructure
Government and critical infrastructure is a Question Mark for Evolv Technologies Holdings, Inc.: CISA defines 16 critical infrastructure sectors, but adoption in government, utilities, and key sites is still early. That makes the addressable market large, yet penetration remains low, so this is a classic invest-or-walk-away category. If Evolv can win a few anchor accounts, the upside is meaningful.
International expansion
Evolv Technologies Holdings, Inc. still has a small international base: FY2025 revenue was $108.8 million, while non-U.S. security screening demand remains spread across airports, stadiums, and venues with uneven procurement rules. That makes international expansion a growth bet, not a proven edge, because domestic U.S. demand is still the clearer scale opportunity.
- Non-U.S. demand exists, but is fragmented.
- International share likely trails U.S. share.
- 2025 revenue: $108.8 million.
Evolv Edge scale-up
Evolv Edge targets a broader threat set than the core Express platform, so it can win larger site deals if buyers want wider coverage. Like most new products, Edge starts with low share even when the addressable market is big, and that is why it still sits in Question Mark territory. If adoption speeds up, it could move toward Star status, but for now the scale-up case is still early.
- Broader threat coverage than Express
- Low share is normal in early scale-up
- Adoption pace decides Star potential
Question Marks: Early But Real Upside for Evolv’s New Markets
Question Marks for Evolv Technologies Holdings, Inc. are the airport, transit, government, and international lines: all have real demand, but share is still low and sales cycles are slow. FY2025 revenue was $108.8 million, so these bets are still early.
| Segment | Status | Signal |
|---|---|---|
| Airports | Question Mark | High upside, slow wins |
| Transit | Question Mark | Long cycles, tough rivals |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.